HGH Frag 176-191 is a peptide fragment derived from human growth hormone (HGH). It's a modified section of the full HGH molecule, containing amino acids 176-191. This fragment has been the subject of research due to its potential effects on fat metabolism.
HGH Frag 176-191 5mg
$44.95Price
HGH Frag 176-191 is a peptide fragment derived from human growth hormone (HGH). It specifically corresponds to the segment of HGH spanning amino acids 176 to 191.
Key points about HGH Frag 176-191:
- Primarily associated with fat loss: It is designed to target adipose tissue and promote lipolysis (fat breakdown).
- Differs from full HGH: Unlike full-length HGH which has broader effects on growth and metabolism, HGH Frag 176-191 focuses on fat reduction.
- Mechanism of action: It regulates the breakdown of fat cells and enhances metabolic rate. It does this by interacting with fat metabolism pathways and promoting lipolytic activity.
- Potential uses:
- Fat loss: HGH Frag 176-191 is explored for its potential in targeted fat reduction and obesity management.
- Research purposes: It is used in laboratory settings to study the mechanisms of HGH and growth hormone-releasing factor (GRF).
- Cancer research: It has been studied in combination with chemotherapy agents to potentially enhance their toxicity against cancer cells.
- Administration: Typically administered via subcutaneous injections, often twice daily into the abdominal area.
- Side effects: Possible side effects include increased insulin resistance and localized reactions at the injection site.
- Limited human studies: Research on HGH Frag 176-191, particularly on its lipolytic effects in humans, is limited and needs further investigation.